Food

Addentax Invests Equity Stake in Fresh Food Marketing Solution Provider, Well Information Technology Corporation

SHENZHEN,China,Jan. 13,2025-- Addentax Group Corp. ("Addentax" or the "Company") (Nasdaq: ATXG),an integrated service provider focusing on garment manufacturing,logistics services,

01-14

Neuromodulation Wristband ObeEnd Reduces Heart Rate and Perceived Exercise Exertion

VANCOUVER,BC,Jan. 13,2025-- WAT Medical Enterprise collaborated with Concordia University and Mitacs Canada to conduct a study using ObeEnd,the neuromodulation device designed by WAT for weight and he

01-14

Yiwu Brands Unite for Overseas Expansion with Grand Opening of Yiwu Selection Store

YIWU,China,Jan. 13,2025-- Yiwu,the world\'s preeminent hub for small commodities,hosts an extensive trading network connecting the globe with 47 industries and 12 million products. As competition in t

01-14

COSRX Celebrates Global Success at SeoulCon's K-Beauty Boost Event

NEW YORK,Jan. 13,2025--COSRX,a trailblazer in the K-Beauty industry,wrapped up 2024 on a high note by participating in the K-Beauty Boost at SeoulCon,a prominent year-end creator conference hosted by

01-14 COSRX

LG Innotek Reasserts Its Leadership in the Future Mobility Market at CES 2025

Exhibition booth attracts 65,000 cumulative visitors,showcasing innovative mobility components Innovative technologies presented through a \'User-Centric storytelling\' approach elicit strong acclaim

01-14 LG Innotek

Nature's Miracle Holding, Inc. Announces Up to $29.7 Million Financing

ONTARIO,Calif.,Jan. 13,2025-- Nature\'s Miracle Holding,Inc. (Nasdaq: NMHI) ("Nature\'s Miracle"),a growing agriculture technology company providing equipment and services to growers,announc

01-14 Nature's Miracle Holding Inc.

Regor Releases Phase 2a Topline Results for RGT-075, an Oral Once-daily Small Molecule GLP-1R Agonist, and Begins Phase 2b Study in the US for the Treatment of Obesity

Regor announced its 12-week single-dose Phase 2a trial results for RGT-075,a once-daily oral GLP-1RA,reporting 5% placebo-adjusted weight-loss with no plateau

01-13 Regor Therapeutics

EngineAI Debuts at CES 2025 with Revolutionary Robotics Lineup

LAS VEGAS,Jan. 10,2025-- On Jan 7-10,Shenzhen EngineAI Robotics,an innovator in humanoid robots,debuted at the prestigious CES 2025,showcasing its humanoid robots: the SE01,SA01,and PM01. These robots

01-11

China Telecom's TeleNavi: Voice-Only Intelligent Location Technology Helps to Break Through 'The Digital Travel Dilemma' For the Elderly

HONG KONG,Jan. 10,2025-- The \'Digital Travel Dilemma\' of the Elderly The internet is evolving at an unprecedented pace,significantly enhancing convenience for young people,while the elderly are in

01-11

XPPen Unveils Artist Pro 22 (Gen 2) with 2.5 K High-Performance 22-inch Drawing Display

LOS ANGELES,Jan. 10,2025-- Today,XPPen has officially launched a remarkable addition to its professional digital drawing display lineup: the Artist Pro 22 (Gen 2),a 22-inch unparalleled drawing displa

01-11 XPPen Technology Co., Ltd.